Clinical trial
A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus…
NCT00244608 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00244608 |
|---|---|
| Title | A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® |
| Official title | A Comparison of the Inflammatory Control of Asthma Provided by One Inhalation of Symbicort® Turbuhaler® 160/4.5 µg/Inhalation b.i.d. Plus As-needed Versus One Inhalation of Symbicort® Turbuhaler® 320/9 µg/Inhalation b.i.d. + One Inhalation of Pulmicort® Turbuhaler® 400 µg/Dose b.i.d. Plus… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/Formoterol Turbuhaler, Budesonide Turbuhaler (Pulmicort), Terbutaline Turbuhaler |
| Enrollment | 100 |
| Start date | May 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Oct 27, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Denmark, France, Germany, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: